Revolution Medicines Inc - Bathi mangsa ngarep RVMD

RVMD (Revolution Medicines Inc) - tandha merek perusahaan

Revolution Medicines (RVMD) is currently in the R&D stage, meaning its operations are independent of economic cycles. The trend of prospective revenues visualizes the market consensus, where the mark reflects the current state. The business relies on the development of targeted agents to block the RAS pathway. High potential demand in lung and pancreatic cancer therapies forms the foundation for future commercial growth.

RVMD: Bathi mangsa ngarep revmed.com 04.07.2022 - 18.11.2026

RevMed - rincian analitis lan metrik utama (RVMD)

Analisis fundamental perusahaan:RVMD, Revolution Medicines, Inc.
Barang utama Revolution Medicines Inc

Investment risks for Revolution Medicines (RVMD) are driven by a lack of current revenue and a high cash burn rate during clinical trials. Under these conditions, the company's future profit projections become a key indicator reflecting the trend of consensus net income per share forecasts, allowing investors to assess the monetization potential of developments and avoid freezing capital by purchasing the asset at the peak of expectations.

Analisis pesaing Revolution Medicines

Bathi mangsa ngarep ONC|HALO: Penghasilan resik sing dikarepake|Bathi mangsa ngarep AAPG (Ascentage)|CGON (CG Oncology Corp) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep URGN (urogen.com)|BCAX - Bathi mangsa ngarep|PSNL: Bathi mangsa ngarep|ERAS - Proyeksi bathi mangsa ngarep|Delcath (DCTH) - Bathi sing dikarepake|YmAbs - Penghasilan resik sing dikarepake|AURA (Aura Biosciences Inc) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Candel Therapeutics CADL|Proyeksi bathi mangsa ngarep ARAY|SLS - Bathi resik sing dikarepake|Proyeksi bathi mangsa ngarep ACTU (Actuate Therapeutics Inc)|Prakiraan bathi perusahaan Citius Oncology, Inc. (CTOR)|TuHURA Biosciences - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Protara Therapeutics, Inc.|FATE: Proyeksi bathi mangsa ngarep|WHWK - Prakiraan bathi perusahaan|Bathi sing dikarepake TScan Therapeutics, Inc.|Champions Oncology - Bathi forward|Proyeksi bathi mangsa ngarep XBIT|Prakiraan bathi perusahaan CEL-SCI Corp|Bathi sing dikarepake OS Therapies OSTX|Penghasilan resik sing dikarepake RADX|artivabio.com - Proyeksi bathi mangsa ngarep|Penghasilan resik sing dikarepake ANL (Adlai Nortye Ltd)|VERU (verupharma.com) - Bathi mangsa ngarep|TPST: Bathi resik mangsa ngarep|XLO (Xilio) - Proyeksi bathi mangsa ngarep|renovarobio.com (RENB) - Prakiraan bathi perusahaan|Bathi sing dikarepake Mural Oncology (MURA)|KAPA (Kairos Pharma Limited) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep OKUR (OnKure Therapeutics, Inc.)|Penghasilan resik sing dikarepake GDTC|Curis Inc. - Proyeksi bathi mangsa ngarep|APLM (apollomicsinc.com) - Prakiraan bathi resik|THAR: Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Advanced Biomed Inc. (ADVB)|Bathi sing dikarepake Genprex, Inc|Proyeksi bathi mangsa ngarep calidibio.com|Bathi sing dikarepake Sunshine Biopharma (SBFM)|Xenetic Biosciences, Inc. - Prakiraan bathi resik|Proyeksi bathi mangsa ngarep SLRX (salariuspharma.com)|Purple Biotech - Bathi sing dikarepake|AONC: Bathi mangsa ngarep|BGNE - Proyeksi bathi mangsa ngarep|CKPT (checkpointtx.com) - Bathi mangsa ngarep|Bathi resik sing dikarepake elevationoncology.com (ELEV)|Bathi mangsa ngarep ICAD|ikenaoncology.com (IKNA) - Prakiraan bathi perusahaan|Bathi sing dikarepake Notable Labs, Ltd. (NTBL)|Bathi sing dikarepake VIRX (Viracta Therapeutics, Inc.)|Proyeksi bathi mangsa ngarep MOR (MorphoSys Inc)|Proyeksi bathi mangsa ngarep NAYA Biosciences Inc NAYA|AAPGV - Bathi sing dikarepake